3 Low-Volatility Stocks We’re Skeptical Of
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here are three low-volatility stocks that don’t make the cut and some better opportunities instead.
Timken (TKR)
Rolling One-Year Beta: 0.79
Established after the founder noticed the difficulty freight wagons had making sharp turns, Timken (NYSE:TKR) is a provider of industrial parts used across various sectors.
Why Do We Pass on TKR?
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Earnings per share have dipped by 2.5% annually over the past two years, which is concerning because stock prices follow EPS over the long term
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Timken’s stock price of $115.71 implies a valuation ratio of 17.2x forward P/E. Dive into our free research report to see why there are better opportunities than TKR.
West Pharmaceutical Services (WST)
Rolling One-Year Beta: 0.90
Founded in 1923 and serving as a critical link in the pharmaceutical supply chain, West Pharmaceutical Services (NYSE:WST) manufactures specialized packaging, containment systems, and delivery devices for injectable drugs and healthcare products.
Why Does WST Worry Us?
- 5.7% annual revenue growth over the last five years was slower than its healthcare peers
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 5.3 percentage points
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
At $383.26 per share, West Pharmaceutical Services trades at 41.2x forward P/E. Read our free research report to see why you should think twice about including WST in your portfolio.
Simmons First National (SFNC)
Rolling One-Year Beta: 0.38
With roots dating back to 1903 and a presence across Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas, Simmons First National (NASDAQ:SFNC) is a regional bank holding company that provides banking and financial services to individuals and businesses.
Why Is SFNC Risky?
- Annual net interest income growth of 6.1% over the last five years was below our standards for the banking sector
- Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 4.5% annually
- Annual tangible book value per share declines of 4.9% for the past five years show its capital management struggled during this cycle
Simmons First National is trading at $22.08 per share, or 0.9x forward P/B. To fully understand why you should be careful with SFNC, check out our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.